Hearts & Minds Blog

ACC Scientific Session Reflections: A Conversation Among Members of The Lipid Management Team

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Mary McGowan

Chief Medical Officer

Tim Mayleben

President and Chief Executive Officer

Last week The Lipid Management team attended the American College of Cardiology (ACC) 66th Annual Scientific Session in Washington D.C…. more

Bempedoic Acid Mechanism of Action Paper Published in Nature Communications: Q&A with the Authors

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Narendra Lalwani, PhD, MBA, FAHA

Executive Vice President, Research and Development, and Chief Operating Officer

Steve Pinkosky

Senior Scientist, Head of Translational Research

As you may have seen, Esperion scientists and collaborators recently published the definitive paper on the mechanism of action for… more

Highlights from the 2016 ESC Congress

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Tim Mayleben

President and Chief Executive Officer

Buongiorno from the ESC Congress! Earlier this week we had the opportunity to attend the 2016 European Society of Cardiology… more

AHA 2014 Scientific Sessions: IMPROVE-IT Results Reported and What They Mean for the Future of ETC-1002

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Tim Mayleben

President and Chief Executive Officer

Last month, the American Heart Association (AHA) held its annual Scientific Sessions in Chicago, IL where presenters and attendees gathered… more

NLA 2014 Scientific Sessions: Placing the Focus on Statin Intolerance

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Roger Newton, PhD, FAHA

Executive Chairman and Chief Scientific Officer

As members of the Esperion team developing ETC-1002—a unique, first-in-class, orally available, once-daily small molecule designed to lower low density… more